FDA Inspection 1333244 — Onyx Healthcare USA, Inc.

Onyx Healthcare USA, Inc. — FEI 3010209365

The FDA completed an inspection of Onyx Healthcare USA, Inc. on Jul 13, 2026 in Orange, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 13, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Orange, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.